A team in Canada has made a device that could be implanted behind the eye to release drugs on demand to treat retinal damage caused by diabetes. Diabetic retinopathy can lead to blindness. A current treatment is laser therapy, which is destructive and results in side effects, such as diminished side and night vision, and unwanted laser burns. Another therapy is to administer antiproliferative drugs, such as docetaxel (normally a cancer drug), but the compounds clear from the blood quickly, so high doses are needed to produce the desired effect, which increases toxicity to other tissues. Mu Chiao and colleagues from the...